Minds AI provides mental health tools using psychological and physical indicators, biotechnology, and artificial intelligence.
Founded in 2019 and based in Seoul, South Korea, Minds AI develops mental health services using biotechnology and artificial intelligence. Its offerings include the PROVE Test for depression and stress analysis, VR-based emotional regulation programs, and psychological counseling. In May 2024, it raised KRW 1 billion in Series A funding led by Stonebridge Ventures and Yonsei Technology Holdings. It collaborates with Gangnam Severance Hospital and the National Center for Mental Health.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in